| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3949830 | Gynécologie Obstétrique & Fertilité | 2006 | 4 Pages |
Abstract
In the English literature published, although the prevalence of abnormalities in human is low (1,7%) during pregnancy, due to the potent teratogenicity, efavirenz is contraindicated in the first trimester and should be used with caution in women of childbearing potential.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
V. Jeantils, M.-A. Khuong, J.-L. Delassus, P. Honoré, B. Taverne, M. Uzan, S. Tassi,